Sense and antisense: Therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders

Clinical Reviews in Allergy and Immunology

Volumn 27, Issue 3, 2004, Pages 207-217

  Ball, Howard A ^a   Van Scott, Michael K ^b   Robinson, Cynthia B ^a  

^a Epigenesis Pharmaceuticals Inc   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Adenosine; Airway hyperreactivity; Antisense; Asthma

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE PHOSPHATE; ANTISENSE OLIGONUCLEOTIDE; BRADYKININ B2 RECEPTOR; CHEMOKINE; CYTOCHROME P450; CYTOKINE RECEPTOR; DINUCLEOTIDE; DNA; EPI 2010; FOMIVIRSEN; G PROTEIN COUPLED RECEPTOR; GENE PRODUCT; GROWTH FACTOR; MESSENGER RNA; PHOSPHATASE; PHOSPHOROTHIOIC ACID DERIVATIVE; PROTEIN; PROTEIN TYROSINE KINASE; RNA; SALBUTAMOL; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ALLERGIC DISEASE; ASTHMA; BIOAVAILABILITY; CLINICAL TRIAL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; NONHUMAN; PRACTICE GUIDELINE; REVIEW; RNA INTERFERENCE; RNA SEQUENCE;

ASTHMA; HUMANS; HYPERSENSITIVITY; OLIGONUCLEOTIDES, ANTISENSE; RNA INTERFERENCE;

EID: 13444271721     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1385/CRIAI:27:3:207     Document Type: Review

References (30)

1. Sears, M.R. (1995), J Invest Allergol Clin Immunol 5, 66-72.
2. http://www.aafa.org. Accessed on Oct. 28, 2004.
3. Zimmermann, N., Moulton, E.A., Aronow, B.J., et al. (2002), J Allergy Clin Immunol 109(1 suppl), S296,905.
4. Dove, A. (2002), Nature Biotech 20, 121-124.
5. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998), Nature 391(6669), 806-811.
6. Eric, G. (2001), Current Biology 11, R772-R775.
7. Nyce, J.W., and Metzger, W.J. (1997), Nature 385(6618), 721-725. Erratum in: (1997) Nature 390(6658), 424.
8. Nyce, J.W., and Metzger, W.J. (1997), Nature 385(6618), 721-725. Erratum in: (1997) Nature 390(6658), 424.
9. Kandimalla, E.R., Yu, D., and Agrawal, S. (2002), Curr Opin Mol Ther 4(2), 122-129.
10. Karol, M.H. (1994), Eur Respir J 7(3), 555-568.
11. Zou, J., Young, S., Zhu, F., et al. (2002), Genome Biol. 3(5), research0020. Epub 2002 Apr 11.
12. Agrawal, S. (1999), Biochim Biophys Acta 1489(1), 53-68.
13. Levin, A.A. (1999), Biochim Biophys Acta 1489(1), 69-84.
14. Cho-Chung, Y.S. (2002), Curr Opin Investig Drugs 3(6), 934-939.
15. Tamm, I., Dorken, B., and Hartmann, G. (2001), Lancet 358(9280), 489-497.
16. de Smet, M.D., Meenken, C.J., and van den Horn, G.J. (1999), Ocul. Immunol. Inflamm. 7, 189-198.
17. Ali, S., Leonard, S.A., Kukoly, C.A., et al. (2001), Am J Respir Crit Care Med 163, 989-993.
18. Nicklin, P.L., Bayley, D., Giddings, J., et al. (1998), Pharm Res (4), 583-591.
19. Agrawal, S. (1999), Biochim Biophys Acta 1489, 53-68.
20. Wang, H., Cai, Q., Zeng, X., Yu, D., et al. (1999), Proc Natl Acad Sci USA 96, 13,989-13,994.
21. Crooke, S.T. (1999), Antisense Nucleic Acid Drug Dev 8, 115-122.
22. Branch, A.D. (1996), Hepatology 24, 1517-1529.
23. Coulson, J.M., Poyner, D.R., Chabtry, A., et al. (1996), Mol Pharmacol 50, 314-325.
24. Dapic, V., Bates, P.J., Trent, J.O., et al. (2002), Biochemistry 41(11), 3676-3685.
25. Finotto, S., De Sanctis, G.T., Lehr, H.A., et al. (2001), J Exp Med 193(11), 1247-1260.
26. Finotto, S., Buerke, M., Lingnau, K., et al. (2001), J Allergy Clin Immunol 107(2), 279-286.
27. Stenton, G.R., Kim, M.K., Noharo, O., et al. (2000), J Immunol 164(10), 5532.
28. Stenton, G.R., Ulanova, M., Dery, R.E., et al. (2002), J Immunol 169(2), 1028-1036.
29. Allakhverdi, Z., Allam, M., and Renzi, P.M. (2002), Am J Respir Crit Care Med 165, 1015-1021.
30. Nakanishi, A., Morita, S., Iwashita, H., et al. (2001), Proc Natl Acad Sci USA 98(9), 5175-5180.